Company
Petal Surgical
Surgery that doesn’t cut.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- For Hospitals
Record updated 28 September 2026
About
Petal is redefining surgery with an intricate interplay of precisely directed sound waves with diseased cells. Our platform uses Millisecond Pulse Histotripsy (a unique form of histotripsy) to cause Acoustic Liquefaction - focused acoustic energy to break down targeted tissue without incisions, heat, or trauma enabling the body to heal itself naturally.
Funding snapshot
- Total raised
- $17.7MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Undisclosed2026-06-07
Funding rounds
- Round, 2026
- 2026-06-07
- Round, 2025
- $17.7M2025-08-14, SEC form D sold, 40 investors
Products
- Hardware
- Petal incisionless surgery platform